Latest news
CytomX Therapeutics secures $37M from Regeneron amid Q2 revenue miss - scanx.tradescanx.trade · Fri, 07 Aug 2026 02:21:26 GMTCytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:35:53 GMTCytomX enrolls 113 patients; next colorectal cancer trial planned - Stock TitanStock Titan · Thu, 06 Aug 2026 20:15:00 GMTCytomX Therapeutics Chief Legal Officer Alejandra Carvajal files initial beneficial ownership statement - BitgetBitget · Wed, 05 Aug 2026 15:32:45 GMTCytomX Therapeutics names Alejandra Carvajal chief legal officer - BitgetBitget · Mon, 03 Aug 2026 07:00:00 GMT